Skip to search.
 FTSE 100 Down 0.33%

More On GLAXF

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

GlaxoSmithKline plc (GLAXF)

-Other OTC Ticker: 925288/ISIN: GB0009252882
18.72 Up 0.21(1.13%) 2 Dec 20:35
Prev Close:18.51
Open:18.55
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:1.24569
Next Earnings Date:N/A
Day's Range:18.55 - 18.83
52wk Range:18.30 - 22.98
Volume:2,561
Avg Vol (3m):3,698
Market Cap:95.10b
P/E (ttm):243.12
EPS (ttm):0.08
Div & Yield:0.95 (5.11%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):0.17
P/S (ttm):2.72
Ex-Dividend Date:03-Nov-16

Analysts

Annual EPS Est (Dec-16) :100.45
Quarterly EPS Est (Dec-16) :21.89
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):1.22

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, including vaccines, over-the-counter medicines, and health-related consumer products worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback